Sandra Cohen

发表

Photodepletion differentially affects CD4+ Tregs versus CD4+ effector T cells from patients with chronic graft-versus-host disease.

D. Allan, C. Perreault, C. Scotto, 2010, Blood.

Efficacy of mycophenolate mofetil in the treatment of chronic graft-versus-host disease.

A. Nademanee, A. Krishnan, G. Somlo, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Graft-versus-host disease prophylaxis with tacrolimus and mycophenolate mofetil in HLA-matched nonmyeloablative transplant recipients is associated with very low incidence of GVHD and nonrelapse mortality.

G. Sauvageau, L. Busque, S. Lachance, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Real-world outcomes of autologous and allogeneic hematopoietic stem cell transplantation for relapsed/refractory Hodgkin lymphoma in the era of novel therapies: a Canadian perspective.

G. Sauvageau, I. Ahmad, H. Alaoui, 2021, Transplantation and cellular therapy.

Outcome of autologous hematopoietic stem cell transplant in older patients with B cell lymphoma when selected for fitness and chemosensitive disease.

G. Sauvageau, I. Ahmad, S. Lachance, 2019, Leukemia research.

Hematopoietic stem cell transplantation using single UM171-expanded cord blood: a single-arm, phase 1-2 safety and feasibility study.

G. Sauvageau, S. Landais, S. Lemieux, 2019, The Lancet. Haematology.

Outcomes in newly diagnosed young or high-risk myeloma patients receiving tandem autologous/allogeneic transplant followed by bortezomib maintenance: a phase II study

G. Sauvageau, S. Landais, D. Ogez, 2021, Bone Marrow Transplantation.

UM171 expansion of cord blood improves donor availability and HLA matching for all patients, including minorities.

G. Sauvageau, W. van't Hof, Marie-Christine Meunier, 2022, Transplantation and cellular therapy.

Autologous and allogeneic stem-cell transplantation for transformed follicular lymphoma: a report of the Canadian blood and marrow transplant group.

J. Connors, K. Savage, T. Panzarella, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Small molecule regulation of normal and leukemic stem cells

G. Sauvageau, I. Fares, Sandra Cohen, 2015, Current opinion in hematology.

Evaluation of the Impact of Autologous Hematopoietic Stem Cell Transplantation on the Quality of Life of Older Lymphoma Patients.

G. Sauvageau, I. Ahmad, S. Lachance, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tandem autologous-allogeneic nonmyeloablative sibling transplantation in relapsed follicular lymphoma leads to impressive progression-free survival with minimal toxicity.

G. Sauvageau, L. Busque, I. Ahmad, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic hematopoietic cell transplantation following reduced intensity conditioning for treatment of myelofibrosis.

S. Forman, D. Snyder, V. Pullarkat, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High incidence of invasive aspergillosis associated with intestinal graft-versus-host disease following nonmyeloablative transplantation.

G. Sauvageau, L. Busque, S. Lachance, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pyrimidoindole derivatives are agonists of human hematopoietic stem cell self-renewal

G. Sauvageau, P. Zandstra, E. Csaszar, 2014, Science.

UM171-expanded cord blood transplants support robust T cell reconstitution with low rates of severe infections.

G. Sauvageau, S. Lemieux, C. Perreault, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Single UM171‐expanded cord blood transplant can cure severe idiopathic aplastic anemia in absence of suitable donors

G. Sauvageau, L. Busque, I. Ahmad, 2020, European journal of haematology.

results of the German CLL Study Group CLL3X trial poor-risk chronic lymphocytic leukemia: long-term clinical and MRD Allogeneic stem cell transplantation provides durable disease control in

N. Schmitz, M. Hallek, S. Stilgenbauer, 2011 .

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia: long-term clinical and MRD results of the German CLL Study Group CLL3X trial.

N. Schmitz, H. Döhner, M. Hallek, 2010, Blood.

Allogeneic stem cell transplantation provides durable disease control in poor-risk chronic lymphocytic leukemia : long-term clinical and MRD results of the German CLL Study Group CLL 3 X trial

N. Schmitz, H. Döhner, M. Hallek, 2010 .

Incidence and prognostic value of eosinophilia in chronic graft-versus-host disease after nonmyeloablative hematopoietic cell transplantation.

G. Sauvageau, L. Busque, I. Ahmad, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Biopsy Proven Late-Onset Sinusoidal Obstruction Syndrome Successfully Treated With Defibrotide

I. Ahmad, S. Lachance, H. Jamali, 2015 .

Impact of Implementing a Bendamustine-based Conditioning Regimen on outcomes of Autologous Stem Cell Transplant in Lymphoma while Novel Cellular Therapies Emerge.

G. Sauvageau, I. Ahmad, I. Fleury, 2022, Transplantation and cellular therapy.

Newly diagnosed multiple myeloma patients treated with tandem auto‐allogeneic stem cell transplant have better overall survival with similar outcomes at time of relapse compared to patients who received autologous transplant only

G. Sauvageau, S. Landais, I. Ahmad, 2020, Clinical transplantation.

Bortezomib maintenance after allogeneic transplantation in newly diagnosed myeloma patients results in decreased incidence and severity of chronic GVHD.

G. Sauvageau, I. Ahmad, S. Lachance, 2022, Transplantation and cellular therapy.

Transplant for non-malignant disorders: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee report on the role of alternative donors, stem cell sources and graft engineering.

R. Ciccocioppo, Athena L. Russell, S. Prockop, 2023, Cytotherapy.

High incidence of herpes zoster in nonmyeloablative hematopoietic stem cell transplantation.

D. Kent, V. Martel-Laferrière, D. Snydman, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Curative therapy for hemoglobinopathies: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review comparing outcomes, accessibility and cost of ex vivo stem cell gene therapy versus allogeneic hematopoietic stem cell transplantation.

Athena L. Russell, S. Prockop, J. Boelens, 2021, Cytotherapy.

Guidelines for Cord Blood Unit Selection.

J. Wagner, E. Shpall, A. Scaradavou, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Blood stem cell products: toward sustainable benchmarks for clinical translation.

Sandra Cohen, Elizabeth Csaszar, Peter W. Zandstra, 2013, BioEssays : news and reviews in molecular, cellular and developmental biology.

Defining the role of sirolimus in the management of graft-versus-host disease: from prophylaxis to treatment.

S. Lachance, T. Kiss, Sandra Cohen, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Viral infection in hematopoietic stem cell transplantation: an International Society for Cell & Gene Therapy Stem Cell Engineering Committee review on the role of cellular therapy in prevention and treatment.

R. Ciccocioppo, M. Stanojevic, Athena L. Russell, 2022, Cytotherapy.

Safety and cost-effectiveness of outpatient autologous stem cell transplantation in patients with multiple myeloma.

G. Sauvageau, L. Busque, I. Ahmad, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allodepleted T‐cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft‐versus‐host disease (GVHD) in the absence of GVHD prophylaxis

G. Sauvageau, C. Perreault, K. Rezvani, 2019, British journal of haematology.

Haploidentical Stem Cell Transplantation: High Doses of Alloreactive-T Cell Depleted Donor Lymphocytes Administered Post-Transplant Decrease Infections and Improve Survival without Causing Severe Gvhd.

G. Sauvageau, L. Busque, D. Fish, 2009 .

Favorable outcomes from allogeneic and autologous stem cell transplantation for patients with transformed nonfollicular indolent lymphoma.

J. Connors, K. Savage, T. Panzarella, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic and Autologous Stem Cell Transplantation for Acute Leukemia and Myelodysplasia in the Adult

S. Forman, Sandra Cohen, S. Cohen, 2004 .

Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome

G. Sauvageau, I. Ahmad, D. Roy, 2022, Current oncology.

Expanding the indications for ibrutinib : complete remission obtained by induction with ibrutinib followed by consolidative aHSCT in refractory primary CNS lymphoma

G. Sauvageau, L. Busque, I. Ahmad, 2020 .

Allogeneic Stem Cell Transplantation Can Overcome the Adverse Prognostic Impact of TP53 Mutation In Chronic Lymphocytic Leukemia (CLL): Results From the GCLLSG CLL3x Trial

N. Schmitz, H. Döhner, M. Hallek, 2010 .

Risk factors for the development of Clostridium difficile infection in adult allogeneic hematopoietic stem cell transplant recipients: A single‐center study in Québec, Canada

K. Marr, M. Laverdière, C. Lavallée, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

International society for cell & gene therapy stem cell engineering committee: Cellular therapies for the treatment of graft-versus-host-disease after hematopoietic stem cell transplant.

Athena L. Russell, M. Pavel-Dinu, S. Prockop, 2023, Cytotherapy.